LEP and osteoporosis: Although the above knowledge indicates that leptin modulates bone metabolism through the activation of SNS and more and more evidences suggest that low dose β-adrenergic antagonist can improve bone loss and bone fragility despite the difference of the osteoporosis models (11-14), the effect of SNS on leptin in osteoporosis has not been completely clarified.